Lee S. Schwartzberg, MD, FACP of The West Clinic and Ian E. Krop, MD, PhD, of the Dana-Farber Cancer Institute discuss the FERGI trial and data from phase I and phase II studies.
Harry D. Bear, MD, PhD, of Massey Cancer Center, discusses abstract PD2-1, “The...
Ismail Jatoi, MD, PhD, FACS, and Clifford A. Hudis, MD, FACS, discuss the role of ovarian suppression and hormonal therapy in premenopausal women.
Ann H. Partridge, MD, MPH, of Dana-Farber Cancer Institute, on abstract S3-09, “...
Lisa A. Carey, MD, of UNC Lineberger Comprehensive Cancer Center, offers her thoughts on abstract S1-09,
Jack Cuzick, PhD, of the Wolfson Institute of Preventive Medicine, discusses abstract S3-07,
Jack Cuzick, PhD, on the IBIS-I Trial